Mark Your Calendar for BPI Europe 2023!
8-11 May 2023RAI in AmsterdamJulian RibaCEO at Cytena
Profile
CYTENA is a pioneer in automated single-cell cloning. The company’s single-cell dispensing technology is used by most of the top 20 pharma companies for stable cell line development. As CEO of CYTENA, Dr. Julian Riba focuses on Cooperate Strategy, Business Development and Product Management. Prior to his appointment as CEO, he led R&D at CYTENA and helped build the company from its beginnings at the Institute for Microsystems Engineering in Freiburg, Germany. Dr. Riba studied mechanical engineering at the Technical University of Munich and received a Ph.D. from the University of Freiburg.
Agenda Sessions
New solutions for reducing complexity and increasing automation in stable cell line development
, 12:15View Session